STAT | Reporting from the frontiers of health and medicine

STAT+: Pharmalittle: We’re reading about FDA and gene therapies, a kidney disease showdown, and more

Fears about the FDA imposing steep barriers to gene therapies for rare diseases appeared moot at an agency roundtable
favicon
statnews.com
statnews.com
Image for the article: STAT+: Pharmalittle: We’re reading about FDA and gene therapies, a kidney disease showdown, and more